Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 157

    1.

    Effects of the antacids in didanosine tablets on dapsone pharmacokinetics.

    Sahai J, Garber G, Gallicano K, Oliveras L, Cameron DW.

    Ann Intern Med. 1995 Oct 15;123(8):584-7.PMID: 7677298 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Cations in the didanosine tablet reduce ciprofloxacin bioavailability.

    Sahai J, Gallicano K, Oliveras L, Khaliq S, Hawley-Foss N, Garber G.

    Clin Pharmacol Ther. 1993 Mar;53(3):292-7.PMID: 8453847 [PubMed - indexed for MEDLINE]Related articles

    3.

    Effects of didanosine formulations on the pharmacokinetics of amprenavir.

    Shelton MJ, Giovanniello AA, Cloen D, Berenson CS, Keil K, DiFrancesco R, Hewitt RG.

    Pharmacotherapy. 2003 Jul;23(7):835-42.PMID: 12885096 [PubMed - indexed for MEDLINE]Related articles

    4.

    Evaluation of effects of altered gastric pH on absorption of dapsone in healthy volunteers.

    Breen GA, Brocavich JM, Etzel JV, Shah V, Schaefer P, Forlenza S.

    Antimicrob Agents Chemother. 1994 Sep;38(9):2227-9.PMID: 7811056 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Pharmacokinetics of simultaneously administered zidovudine and didanosine in HIV-seropositive male patients.

    Sahai J, Gallicano K, Garber G, Pakuts A, Cameron W.

    J Acquir Immune Defic Syndr Hum Retrovirol. 1995 Sep 1;10(1):54-60.PMID: 7648285 [PubMed - indexed for MEDLINE]Related articles

    7.

    Effect of antacids in didanosine tablet on bioavailability of isoniazid.

    Gallicano K, Sahai J, Zaror-Behrens G, Pakuts A.

    Antimicrob Agents Chemother. 1994 Apr;38(4):894-7.PMID: 8031068 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Lack of effect of nizatidine-induced elevation of gastric pH on the oral bioavailability of dapsone in healthy volunteers.

    Itokazu GS, Fischer JH, Manitpisitkul P, Hariharan R, Danziger LH.

    Pharmacotherapy. 2002 Nov;22(11):1420-5.PMID: 12432968 [PubMed - indexed for MEDLINE]Related articles

    9.

    Pharmacokinetics of dapsone gel, 5% for the treatment of acne vulgaris.

    Thiboutot DM, Willmer J, Sharata H, Halder R, Garrett S.

    Clin Pharmacokinet. 2007;46(8):697-712.PMID: 17655376 [PubMed - indexed for MEDLINE]Related articles

    10.

    Lack of pharmacokinetic interaction between linezolid and antacid in healthy volunteers.

    Grunder G, Zysset-Aschmann Y, Vollenweider F, Maier T, Krähenbühl S, Drewe J.

    Antimicrob Agents Chemother. 2006 Jan;50(1):68-72.PMID: 16377669 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Effect of simultaneous didanosine administration on itraconazole absorption in healthy volunteers.

    May DB, Drew RH, Yedinak KC, Bartlett JA.

    Pharmacotherapy. 1994 Sep-Oct;14(5):509-13.PMID: 7997384 [PubMed - indexed for MEDLINE]Related articles

    12.

    Effect of high-dose oral ganciclovir on didanosine disposition in human immunodeficiency virus (HIV)-positive patients.

    Jung D, Griffy K, Dorr A, Raschke R, Tarnowski TL, Hulse J, Kates RE.

    J Clin Pharmacol. 1998 Nov;38(11):1057-62.PMID: 9824788 [PubMed - indexed for MEDLINE]Related articles

    13.

    Lack of effect of simultaneously administered didanosine encapsulated enteric bead formulation (Videx EC) on oral absorption of indinavir, ketoconazole, or ciprofloxacin.

    Damle BD, Mummaneni V, Kaul S, Knupp C.

    Antimicrob Agents Chemother. 2002 Feb;46(2):385-91.PMID: 11796346 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Bioequivalence of two formulations of didanosine, encapsulated enteric-coated beads and buffered tablet, in healthy volunteers and HIV-infected subjects.

    Damle BD, Kaul S, Behr D, Knupp C.

    J Clin Pharmacol. 2002 Jul;42(7):791-7.PMID: 12092746 [PubMed - indexed for MEDLINE]Related articles

    15.

    Pharmacokinetic properties of combination oxycodone plus racemic ibuprofen: two randomized, open-label, crossover studies in healthy adult volunteers.

    Kapil R, Nolting A, Roy P, Fiske W, Benedek I, Abramowitz W.

    Clin Ther. 2004 Dec;26(12):2015-25.PMID: 15823765 [PubMed - indexed for MEDLINE]Related articles

    16.

    Clinical pharmacokinetics and gastrointestinal tolerability of a novel extended-release microsphere formulation of azithromycin.

    Chandra R, Liu P, Breen JD, Fisher J, Xie C, LaBadie R, Benner RJ, Benincosa LJ, Sharma A.

    Clin Pharmacokinet. 2007;46(3):247-59.PMID: 17328583 [PubMed - indexed for MEDLINE]Related articles

    17.

    Pharmacokinetics of didanosine and ketoconazole after coadministration to patients seropositive for the human immunodeficiency virus.

    Knupp CA, Brater DC, Relue J, Barbhaiya RH.

    J Clin Pharmacol. 1993 Oct;33(10):912-7.PMID: 8227460 [PubMed - indexed for MEDLINE]Related articles

    18.

    Effect of time of food administration on the bioavailability of didanosine from a chewable tablet formulation.

    Knupp CA, Milbrath R, Barbhaiya RH.

    J Clin Pharmacol. 1993 Jun;33(6):568-73.PMID: 8366182 [PubMed - indexed for MEDLINE]Related articles

    19.

    Antacids have no influence on the pharmacokinetics of rabeprazole, a new proton pump inhibitor, in healthy volunteers.

    Yasuda S, Higashi S, Murakami M, Tomono Y, Kawaguchi M.

    Int J Clin Pharmacol Ther. 1999 May;37(5):249-53.PMID: 10363624 [PubMed - indexed for MEDLINE]Related articles

    20.

    Ondansetron absorption in adults: effect of dosage form, food, and antacids.

    Bozigian HP, Pritchard JF, Gooding AE, Pakes GE.

    J Pharm Sci. 1994 Jul;83(7):1011-3.PMID: 7965657 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data